|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
doi: 10.1242/10.1242/jcs.00449
Research Article |

1 Unité INSERM U 396, Institut Biomédical des Cordeliers, 15 rue
de l'Ecole de Médecine, 75006 Paris, France
2 Department of Biological Sciences, University of Maryland, Baltimore, MD
21250, USA
3 Department of Immunology, Institute of Ophthalmology, University College
London, 11-43 Bath Street, London EC1V 9EL, UK
Author for correspondence (e-mail:
nuala.mooney{at}bhdc.jussieu.fr)
Accepted 4 March 2003
In addition to their role in antigen presentation, major histocompatibility
complex (MHC) class II molecules have been widely described as signaling
proteins in diverse antigen-presenting cells (APCs) including B cells and
dendritic cells. By contrast, little is known of the signaling function of MHC
class II molecules expressed in solid tumors. We describe the functional
organization and signaling ability of I-Ak expressed in a sarcoma,
and report the recruitment of I-Ak to lipid rafts after MHC class
II engagement. Lipid raft integrity was required for I-Ak-mediated
reorganization of the actin cytoskeleton and translocation of protein kinase
C-
(PKC-
) to the precise site of stimulation via I-Ak.
Truncation of the intracytoplasmic domains of I-Ak did not perturb
I-Ak recruitment to lipid rafts but abrogated
PKC-
translocation and actin rearrangement. PKC-
was detected in
lipid microdomains and enrichment of activated PKC-
in lipid rafts was
induced by I-Ak signaling. Ordering of the molecular events
following engagement of the MHC class II molecules revealed that
I-Ak recruitment to lipid rafts precedes signaling. This is
consistent with the absence of a requirement for the intracytoplasmic tails
for localization to lipid rafts. These data reveal that lipid-rich
microdomains play a key role in MHC class II-mediated signaling in a solid
tumor.
Key words: Lipid rafts, MHC class II, PKC, Actin, Tumor cell
Related articles in JCS:
This article has been cited by other articles:
![]() |
E. Walseng, O. Bakke, and P. A. Roche Major Histocompatibility Complex Class II-Peptide Complexes Internalize Using a Clathrin- and Dynamin-independent Endocytosis Pathway J. Biol. Chem., May 23, 2008; 283(21): 14717 - 14727. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sloma, M.-T. Zilber, T. Vasselon, N. Setterblad, M. Cavallari, L. Mori, G. De Libero, D. Charron, N. Mooney, and C. Gelin Regulation of CD1a Surface Expression and Antigen Presentation by Invariant Chain and Lipid Rafts J. Immunol., January 15, 2008; 180(2): 980 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Karacsonyi, T. Bedke, N. Hinrichsen, R. Schwinzer, and R. Lindner MHC II molecules and invariant chain reside in membranes distinct from conventional lipid rafts J. Leukoc. Biol., November 1, 2005; 78(5): 1097 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Zilber, N. Setterblad, T. Vasselon, C. Doliger, D. Charron, N. Mooney, and C. Gelin MHC class II/CD38/CD9: a lipid-raft-dependent signaling complex in human monocytes Blood, November 1, 2005; 106(9): 3074 - 3081. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rucci, C. DiGiacinto, L. Orru, D. Millimaggi, R. Baron, and A. Teti A novel protein kinase C {alpha}-dependent signal to ERK1/2 activated by {alpha}V{beta}3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cells J. Cell Sci., August 1, 2005; 118(15): 3263 - 3275. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Drenou, L. Amiot, N. Setterblad, S. Taque, V. Guilloux, D. Charron, R. Fauchet, and N. Mooney MHC class II signaling function is regulated during maturation of plasmacytoid dendritic cells J. Leukoc. Biol., April 1, 2005; 77(4): 560 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Poloso, A. Muntasell, and P. A. Roche MHC Class II Molecules Traffic into Lipid Rafts during Intracellular Transport J. Immunol., October 1, 2004; 173(7): 4539 - 4546. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Karacsonyi, R. Knorr, A. Fulbier, and R. Lindner Association of Major Histocompatibility Complex II with Cholesterol- and Sphingolipid-rich Membranes Precedes Peptide Loading J. Biol. Chem., August 13, 2004; 279(33): 34818 - 34826. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Setterblad, S. Becart, D. Charron, and N. Mooney B Cell Lipid Rafts Regulate Both Peptide-Dependent and Peptide-Independent APC-T Cell Interaction J. Immunol., August 1, 2004; 173(3): 1876 - 1886. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Setterblad, V. Blancheteau, A. Delaguillaumie, F. Michel, S. Becart, G. Lombardi, O. Acuto, D. Charron, and N. Mooney Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells J. Leukoc. Biol., June 1, 2004; 75(6): 1036 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. El Fakhry, M. Bouillon, C. Leveille, A. Brunet, H. Khalil, J. Thibodeau, and W. Mourad Delineation of the HLA-DR Region and the Residues Involved in the Association with the Cytoskeleton J. Biol. Chem., April 30, 2004; 279(18): 18472 - 18480. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Dolan, T. P. Phelan, D. Ilkovitch, L. Qi, W. F. Wade, T. M. Laufer, and S. Ostrand-Rosenberg Invariant Chain and the MHC Class II Cytoplasmic Domains Regulate Localization of MHC Class II Molecules to Lipid Rafts in Tumor Cell-Based Vaccines J. Immunol., January 15, 2004; 172(2): 907 - 914. [Abstract] [Full Text] [PDF] |
||||